Patents by Inventor Charles John O'Donnell

Charles John O'Donnell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Agents 812
    Publication number: 20110065706
    Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as GPR119 modulators, methods for their therapeutic use, particularly in the treatment of obesity and diabetes mellitus, and pharmaceutical compositions containing them.
    Type: Application
    Filed: September 10, 2010
    Publication date: March 17, 2011
    Applicant: AstraZeneca AB
    Inventors: Alan Martin Birch, Roger John Butlin, David Stephen Clarke, Andrew Leach, Philip Alexander MacFaul, Charles John O'Donnell, James Stewart Scott, Paul Robert Owen Whittamore, Dan Anders Broo, Öjvind Percy Davidsson, Kjell Erik Johansson, Hanna De La Motte
  • Therapeutic Agents - 551
    Publication number: 20090118332
    Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as Fatty Acid Synthase inhibitors, methods for their therapeutic use, particularly in the treatment of obesity, diabetes mellitus, cancer and infection and pharmaceutical compositions containing them.
    Type: Application
    Filed: December 20, 2007
    Publication date: May 7, 2009
    Applicant: AstraZeneca AB
    Inventors: Roger John Butlin, Peter William Rodney Caulkett, Andrew Leach, Nicholas John Newcombe, Charles John O'Donnell, James Matthew Wood
  • Therapeutic Agents - 550
    Publication number: 20090105305
    Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as Fatty Acid Synthase inhibitors, methods for their therapeutic use, particularly in the treatment of obesity and diabetes mellitus, cancer and infection and pharmaceutical compositions containing them.
    Type: Application
    Filed: December 20, 2007
    Publication date: April 23, 2009
    Applicant: AstraZeneca AB
    Inventors: Roger John Butlin, Peter William Rodney Caulkett, Petra Johannesson, Laurent Daniel Knerr, Andrew Leach, Nicholas John Newcombe, Charles John O'Donnell, Helen Pointon, James Matthew Wood